
Melanie Kier
Assistant Professor of Medicine · Icahn School of Medicine At Mount Sinai
Credentials: · · · · · ·
History
Research
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma
Nature Medicine · 2019 · 588 citations
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
Nature · 2024 · 178 citations
Cancer Cell · 2024 · 100 citations

2 papers · 2 as a fellow

2 papers
- BZ
2 papers

2 papers

2 papers
- EB
2 papers

2 papers
- JB
2 papers · 2 as a fellow
Clinical trials
- 2024–2030
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
- 2023–2033
Site PI · Recruiting · Phase 3
Alliance for Clinical Trials in Oncology


